naproxen has been researched along with benzoic anhydride in 1 studies
| Studies (naproxen) | Trials (naproxen) | Recent Studies (post-2010) (naproxen) | Studies (benzoic anhydride) | Trials (benzoic anhydride) | Recent Studies (post-2010) (benzoic anhydride) |
|---|---|---|---|---|---|
| 4,551 | 1,057 | 1,429 | 6 | 0 | 4 |
| Protein | Taxonomy | naproxen (IC50) | benzoic anhydride (IC50) |
|---|---|---|---|
| Beta-lactamase class B VIM-2 | Pseudomonas aeruginosa | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brozic, P; Gobec, S; Rizner, TL | 1 |
1 other study(ies) available for naproxen and benzoic anhydride
| Article | Year |
|---|---|
Nonsteroidal anti-inflammatory drugs and their analogues as inhibitors of aldo-keto reductase AKR1C3: new lead compounds for the development of anticancer agents.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Drug Design; Enzyme Inhibitors; Humans; Hydroxyprostaglandin Dehydrogenases; Molecular Structure; Tumor Cells, Cultured | 2005 |